| |
 |
Editorial [Hot Topic: Angiogenesis in Tumor Growth and Metastasis (Executive Editor: Riichiro Abe)]
|
| |
|
pp.3779-3779 (1) Author: Riichiro Abe
|
| |
|
|
| |
|
The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
|
| |
|
pp.3780-3789 (10) Authors: I. Martin-Padura, F. Bertolini
|
| |
|
|
| |
|
Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
|
| |
|
pp.3790-3801 (12) Authors: Carlo Bifulco, Katy McDaniel, Lin Leng, Richard Bucala
|
| |
|
|
| |
|
Pigment Epithelium-Derived Factor Prevents Melanoma Growth via Angiogenesis Inhibition
|
| |
|
pp.3802-3809 (8) Authors: Riichiro Abe, Yasuyuki Fujita, Sho-ichi Yamagishi, Hiroshi Shimizu
|
| |
|
|
| |
|
Color-Coded Fluorescent Protein Imaging of Angiogenesis: The AngioMouse® Models
|
| |
|
pp.3810-3819 (10) Authors: Yasuyuki Amoh, Kensei Katsuoka, Robert M. Hoffman
|
| |
|
|
| |
|
Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
|
| |
|
pp.3820-3834 (15) Authors: Yasuyuki Fujita, Riichiro Abe, Hiroshi Shimizu
|
| |
|
|
| |
|
Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
|
| |
|
pp.3835-3853 (19) Authors: Yan Zhang, Marc Ruel, Rob S.B. Beanlands, Robert A. deKemp, Erik J. Suuronen, Jean N. DaSilva
|
| |
|
|
| |
|
Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
|
| |
|
pp.3854-3872 (19) Authors: P. Srivani, D. Usharani, Eluvathingal D. Jemmis, G. Narahari Sastry
|
| |
|
|
| |
|
Potentials of ES Cell Therapy in Neurodegenerative Diseases
|
| |
|
pp.3873-3879 (7) Authors: Anand S. Srivastava, Rakesh Malhotra, Jason Sharp, Travis Berggren
|
| |
|
|
